US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist
  • 4.930
  • -0.020-0.40%
Close Dec 12 16:00 ET
90.82MMarket Cap-3.68P/E (TTM)

OptimizeRx Key Stats

OptimizeRx Q3 2024 Earnings Date

Currency:USDNov 13, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
25.00M
21.31M
-3.69M
Miss Est.
+53.06%
+30.48%
-14.75%
EPS
-0.19
-0.50
-0.31
Miss Est.
-10.30%
-194.12%
-166.81%
Strong Buy

Dec 12, 2024

OptimizeRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.000M--
--2024/Q4-- / 29.539M--
Nov 13, 20242024/Q321.309M / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.000M--
--2024/Q4-- / 29.539M--
Nov 13, 20242024/Q321.309M / 24.997M--
Aug 8, 20242024/Q218.812M / 20.463M--
May 14, 20242024/Q119.690M / 18.132M--

Unlock Free Earnings Estimates

OptimizeRx Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 12, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data